BRIDGED RING COMPOUND AND USE THEREOF - MEDSHINE DISCOVERY INC

Title:

BRIDGED RING COMPOUND AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2023/011359

Kind Code:

A1

Abstract:

A bridged ring compound and the use thereof in the preparation of a drug for treating related diseases. Specifically disclosed are a compound as represented by formula (I) and a pharmaceutically acceptable salt thereof.

More Like This:

JP5237121	Process for preparing intermediates for 5-HT4 receptor agonist compounds
JP7235742	Novel sulfonamide carboxamide compound
JP2007506709	Benzimidazolone and quinazolinone derivatives as agonists for the human ORL1 receptor

Inventors:

MAO WEIWEI (CN)
YU ZHU (CN)
WEI CHANGQING (CN)
QIAN WENYUAN (CN)
HU SHICHEN (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)

Application Number:

PCT/CN2022/109073

Publication Date:

February 09, 2023

Filing Date:

July 29, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MEDSHINE DISCOVERY INC (CN)

International Classes:

C07D451/04; A61K31/4188; A61K31/46; A61P1/04

Domestic Patent References:

WO2020108613A1	2020-06-04
WO2020108516A1	2020-06-04

Foreign References:

CN107667108A	2018-02-06
CN109071529A	2018-12-21

Attorney, Agent or Firm:

SHANGHAI BESHINING LAW OFFICE (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: NOVEL PHARMACEUTICAL SALTS AND POLYMORPHIC FORMS OF AN ERBB AND BTK INHIBITOR

Next Patent: METHOD FOR ENHANCING SUSTAINED RELEASE CAPABILITY OF NUCLEIC ACID DRUG